News - Management

Filter

Current filters:

Management

Popular Filters

51 to 75 of 229 results

AEterna Zentaris names Richard Sachse as chief scientific officer

04-01-2014

Canadian drugmaker AEterna Zentaris (TSX: AEZ) has appointed Richard Sachse as senior vice president,…

AEterna ZentarisBoardroomManagementPharmaceutical

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

04-01-2014

US drugmaker Mylan says that Rakesh Bamzai has joined the company and has been appointed president, India…

BoardroomGenericsManagementMylan Laboratories

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease

01-01-2014

US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

Report: Health care companies lead the way in corporate compliance

27-12-2013

Health care companies are leading the way in terms of public trust and transparency, according to The…

AstraZenecaGlaxoSmithKlineLegalManagementPharmaceuticalReckitt BenckiserUK

Majority of pharmaceutical companies centralize market access activities

26-12-2013

A new pharmaceutical benchmarking study found that 53% of surveyed companies centralize their market…

ManagementMarkets & MarketingPharmaceutical

Takeda sets sights on Israeli pharma market, with new subsidiary

Takeda sets sights on Israeli pharma market, with new subsidiary

18-12-2013

Through a European subsidiary, Japan’s largest drugmaker Takeda Pharmaceuticals today announced further…

ManagementMarkets & MarketingPharmaceuticalRest of the WorldTakeda Pharmaceuticals

GlaxoSmithKline to ditch sales target-based compensation, change other global marketing practices

GlaxoSmithKline to ditch sales target-based compensation, change other global marketing practices

17-12-2013

In the wake of the bribery scandal in China, as well as a record-breaking $3 billion fine in the USA…

GlaxoSmithKlineGlobalManagementMarkets & MarketingPharmaceutical

Teva vice chairman Moshe Many to leave post for 'personal reasons'

Teva vice chairman Moshe Many to leave post for 'personal reasons'

11-12-2013

Israel’s Teva Pharmaceutical Industries announced yesterday that the vice chairman of its board of…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Should patients appreciate pharma?

Should patients appreciate pharma?

06-12-2013

Here's our take on the week's top stories.

Asia-PacificBayerEuropeFinancialHealthcareManagementPharmaceutical

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Almirall take steps, including cut job, to counter market problems in Europe

05-12-2013

Spain's largest drugmaker Almirall today revealed a reorganization at European level in order to optimize…

AlmirallManagementPharmaceutical

Report 3: Growth strategies in Japan’s pharma market – People - P Reed Maurer

Report 3: Growth strategies in Japan’s pharma market – People - P Reed Maurer

04-12-2013

It is the people that set the Pharma industry apart from other industries. In one company you have an…

Asia-PacificManagementPharmaceutical

Eisai’s R&D organization undergoes “transformation”

Eisai’s R&D organization undergoes “transformation”

30-11-2013

Japanese drugmaker Eisai's president and chief executive, Haruo Naito, says that the company's R&D organization,…

Asia-PacificEisaiEuropeManagementNorth AmericaPharmaceuticalResearchUSA

Takeda names GSK executive as next chief operating officer

Takeda names GSK executive as next chief operating officer

29-11-2013

Japan’s largest drugmaker, Takeda Pharmaceutical, says that Christophe Weber has been approved at the…

BoardroomManagementPharmaceuticalTakeda Pharmaceuticals

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

22-11-2013

US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

Raft of senior management changes at Bristol-Myers Squibb

Raft of senior management changes at Bristol-Myers Squibb

14-11-2013

To support its ongoing success as a BioPharma leader, US drug major Bristol-Myers Squibb says it is evolving…

BoardroomBristol-Myers SquibbManagementPharmaceutical

Japan market entry challenges – by P Reed Maurer

Japan market entry challenges – by P Reed Maurer

14-11-2013

Not long ago, the last word in the title would have been obstacles rather than challenges, says P Reed…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Bristol-Myers Squibb refocuses R&D strategy

Bristol-Myers Squibb refocuses R&D strategy

08-11-2013

US drug major Bristol-Myers Squibb says it is “evolving its strategic focus in R&D to ensure continued…

Anti-viralsBristol-Myers SquibbDiabetesManagementNeurologicalOncologyPharmaceuticalResearch

Home Offices still don’t get Japan - by P Reed Maurer

Home Offices still don’t get Japan - by P Reed Maurer

07-11-2013

Many, fortunately not all, senior managers of foreign pharma companies in Japan constantly struggle with…

Asia-PacificManagementPharmaceutical

Menarini inaugurates its China headquarters in Wuhan Biolake

Menarini inaugurates its China headquarters in Wuhan Biolake

04-11-2013

Family-owned Menarini Group, Italy’s largest biopharma company, has officially launched its China headquarters…

ManagementMenariniPharmaceutical

Teva Pharmaceutical says CEO Jeremy Levin has resigned

Teva Pharmaceutical says CEO Jeremy Levin has resigned

30-10-2013

Israel-based Teva Pharmaceutical Industries, say that, despite its recent denials of a rift with its…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Amarin cuts 50% of staff after negative FDA decision

23-10-2013

Amarin has announced plans to cut 50% of its staff worldwide after the recent US Food and Drug Administration…

AmarinCardio-vascularFinancialManagementNorth AmericaPharmaceuticalVascepa

Investor calls for changes at XenoPort, highlighting Horizant failure

16-10-2013

Clinton Group, one of the 10 largest owners of shares in XenoPort), has written to chief executive Ronald…

FinancialHorizantManagementPharmaceuticalXenoPort

51 to 75 of 229 results

Back to top